Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - A randomized study

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 10, 2011, Pages 1354-1358

  Gisselsson Solén, Marie ^a   Melhus, Åsa ^b   Hermansson, Ann ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Conjugate vaccines; PCV7; Recurrent acute otitis media; Vaccination; Ventilation tube treatment

Indexed keywords

PNEUMOCOCCUS VACCINE;

ABSENCE OF SIDE EFFECTS; ACUTE OTITIS MEDIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFANT; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TYMPANOSTOMY TUBE;

ACUTE DISEASE; CHILD, PRESCHOOL; EMERGENCY TREATMENT; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; RECURRENCE;

EID: 80052838685     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02332.x     Document Type: Article

References (30)

1. Daly KA, Brown JE, Lindgren BR, Meland MH, Le CT, Giebink GS,. Epidemiology of otitis media onset by six months of age. Pediatrics 1999; 103: 1158-66. (Pubitemid 29258787)
2. Alho OP,. How common is recurrent acute otitis media? Acta Otolaryngol SUPPL. 1997; 529: 8-10.
3. Teele DW, Klein JO, Rosner B,. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83-94. (Pubitemid 19162997)
4. Bluestone CD, Stephenson JS, Martin LM,. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11 (8 SUPPL.): S7-11.
5. Block SL,. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997; 16: 449-56. (Pubitemid 27172976)
6. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK,. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20: 654-62. (Pubitemid 32652315)
7. Luntz M, Brodsky A, Nusem S, Kronenberg J, Keren G, Migirov L, et al., Acute mastoiditis - the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol 2001; 57: 1-9. (Pubitemid 32112135)
8. Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM,. Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype - implications for vaccine effect. Clin Infect Dis 2005; 40: 52-7. (Pubitemid 40053459)
9. Control ECfDPa. Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2010.
10. Thornsberry C, Sahm DF,. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study. Chemotherapy 2000; 46 (SUPPL. 1): 15-23. (Pubitemid 30248886)
11. Pichichero ME,. Recurrent and persistent otitis media. Pediatr Infect Dis J 2000; 19: 911-6.
12. Rovers MM, Glasziou P, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, et al., Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 2006; 368: 1429-35. (Pubitemid 44573468)
13. Kalm O, Prellner K, Freijd A, Rynnel-Dagoo B,. Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children. Acta Otolaryngol 1986; 101: 467-74. (Pubitemid 16117347)
14. Karma P, Pukander J, Sipila M, Timonen M, Pontynen S, Herva E, et al., Prevention of otitis media in children by pneumococcal vaccination. Am J Otolaryngol 1985; 6: 173-84. (Pubitemid 15045965)
15. Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA,. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev 2009 (2):CD001480.
16. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al., Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187-95. (Pubitemid 30167436)
17. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al., Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403-9. (Pubitemid 32128672)
18. Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, et al., Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003; 361: 2189-95. (Pubitemid 36782552)
19. van Kempen MJ, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, et al., Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative? Int J Pediatr Otorhinolaryngol 2006; 70: 275-85. (Pubitemid 43053108)
20. Harsten G, Prellner K, Heldrup J, Kalm O, Kornfalt R,. Recurrent acute otitis media. A prospective study of children during the first three years of life. Acta Otolaryngol 1989; 107: 111-9. (Pubitemid 19035861)
21. Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, et al., Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J 2003; 22: 209-16.
22. Sakata H, Fujita K, Yoshioka H,. The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother 1986; 29: 225-9. (Pubitemid 16162929)
23. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P,. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003; 22: 10-6. (Pubitemid 36091771)
24. Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, et al., Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 2007; 119: 707-15. (Pubitemid 46556669)
25. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al., Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23: 829-33. (Pubitemid 40221025)
26. Casey JR, Pichichero ME,. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23: 824-8. (Pubitemid 40221024)
27. Pichichero ME, Casey JR,. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J 2007; 26 (10 SUPPL.): S12-6.
28. Zhou F, Shefer A, Kong Y, Nuorti JP,. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 2008; 121: 253-60. (Pubitemid 351198446)
29. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, et al., National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 2006; 118: 865-73. (Pubitemid 46090026)
30. Jahn-Eimermacher A, du Prel JB, Schmitt HJ,. Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials. Vaccine 2007; 25: 6237-44. (Pubitemid 47088034)